All CAR-Immunotherapy Trials cumulative through end 2017

This CAR-Immunotherapy package contains 22 parameters for all CAR-T trials registered internationally tthrough 31 Dec. 2017. Cumulatively, 421 CAR-Immunotherapy trials have been registered worldwide, including 118 in 2016 and 151 in 2017. Purchasers will receive FREE UPDATES of new CAR-Immunotherapy trials twice a year for the next 3 years after purchase date.

  • Trial Data
    • Registration Year
    • Trial ID with link to trial on-line
    • Country
    • Phase
    • Status (updated as of end of 2017)
  • Patient Data
    • Indication
    • Patient Age Groups
    • Target Enrollment
  • Cell Data
    • CAR Target
    • Cell Type
    • Cell Source
    • Donor Type
    • CAR Construct (costimulatory domain, vector, etc)
    • Cell Dose(s)
    • Mode of Administration (route and # doses)
    • Conditioning
    • Drug Support/Combos
  • Sponsor Data
    • Academia or Industry Funding
    • Sponsor Name
    • Study Acronym
  • Additional Information
    • Product Name
    • Notes - includes secondary trial IDs and reasons for termination

A graph of CAR-Immunotherapy trial numbers versus time shows the explosion of CAR-Immunotherapy trials since 2014 and the appearance of follow-up studies since 2015. There were 118 new CAR-Immunotherapy trials worldwide in 2016, and 28% of them were not registered in ClinicalTrials.gov.

Public samples:
AttachmentSize
Sample-CAR-immunotherapy-trials.xlsx12.19 KB